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Most antitumour agents with cytotoxic properties in-
duce apoptosis. The lipophilic compound euplotin C,
isolated from the ciliate Euplotes crassus, is toxic to a
number of different opportunistic or pathogenic microor-
ganisms, although its mechanism of action is currently un-
known. We report here that euplotin C is a powerful cy-
totoxic and pro-apoptotic agent in mouse AtT-20 and rat
PC12 tumour-derived cell lines. In addition, we provide ev-
idence that euplotin C treatment results in rapid activation
of ryanodine receptors, depletion of Ca2+ stores in the en-
doplasmic reticulum (ER), the release of cytochrome c from
the mitochondria, activation of caspase-12, and activation
of caspase-3, leading to apoptosis. Intracellular Ca2+ over-
load is an early event which induces apoptosis and is paral-
lelled by ER stress and the release of cytochrome c, whereas
caspase-12 may be activated by euplotin C at a later stage in
the apoptosis pathway. These events, either independently
or concomitantly, lead to the activation of the caspase-3
and its downstream effectors, triggering the cell to undergo
apoptosis. These results demonstrate that euplotin C may
be considered for the design of cytotoxic and pro-apoptotic
new drugs.
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Introduction
Finely tuned regulation of intracellular signalling is fun-
damental for cell survival and death. In particular, cell
demise does not always result from a collapse of home-
ostatic control systems but is often an active and highly
regulated process.1–5 Cell death can be induced by two
mechanisms: necrosis and apoptosis. Necrosis has tradition-
ally been thought of as simply a passive, unorganized form of
cell death whereas apoptosis is a more programmed process
and is the principal mechanism by which cells are physio-
logically eliminated. Alternatively, non-apoptotic forms of
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programmed cell death have been recently described and
classified as programmed necrosis or autophagic cell death.5
Apoptosis is an intrinsic cellular suicide mechanism and is
a relatively linear process. It is triggered by an initiation
phase that is highly varied depending on cell type and the
underlying stimulus. This is followed by an effector phase
where the cell undergoes distinct biochemical changes that
result in the systematic activation of catabolic enzymes (pro-
teases and/or nucleases) that ultimately cause the cleavage of
proteins and DNA.3,4 Induction of apoptosis is arguably the
body’s most potent defence against cancer. Indeed, immune
system cells destroy cancerous cells, and most chemothera-
peutic and chemopreventive agents inhibit tumour cell pro-
liferation, by inducing apoptosis.6–9 Unfortunately, these
agents are of limited use for clinical applications owing to
their inherent lack of stability, specificity, limited solubility,
and poor cell permeability.9 Currently, a great deal of effort
is being aimed at replacing the existing drugs by novel com-
pounds targeting specific apoptosis regulators, which could
set the stage for future therapeutics.
Cellular apoptosis is ultimately caused by the activa-
tion of caspases (cysteine proteases). Active initiator cas-
pases can proteolyze additional executioner caspases, for in-
stance caspase-3, generating a caspase cascade that cleaves
proteins critical for cell survival. Currently a number of
different mechanisms of apoptosis have been characterised
which may overlap due to their cross-talk and which may
or may not be associated with caspase activation.1,2,6,7 Re-
cent developments have emphasized the central role of Ca2+
in cell death pathways. Indeed, Ca2+ depletion from intra-
cellular stores can activate distinct stages of the cell death
programme, which can then function alone or in conjunction
with other sub-programmes to kill the cell.2 Growing evi-
dence suggests that, in addition to the injured mitochondria
which release cytochrome c and other apoptogenic factors,
other organelles are also major points of integration for pro-
apoptotic signalling and caspase activation.1 For instance,
the endoplasmic reticulum (ER) participates in the initia-
tion of apoptosis through at least two different mechanisms,
namely the unfolded protein response and Ca2+ signalling
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